Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccinationValeria Fumagalli, Matteo Iannacone|Nature Immunology|2024Cited by 55
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infectionKami Pekayvaz, Leo Nicolai, Valeria Fumagalli et al.|Nature Communications|2022Cited by 41
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell developmentStefanie Scherer, Dietmar Zehn, Susanne Oberle et al.|Nature Immunology|2023Cited by 31
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responsesValeria Fumagalli, Matteo Iannacone|EMBO Molecular Medicine|2023Cited by 26